Galectin Therapeutic (GALT)
$3.73
0.04 (1.08%)
GALT Stock Quote Delayed 15 Minutes
Previous Close
$3.73
Market Cap
140.77M
PE Ratio
-8.11
EPS
-0.46
Volume (Avg. Vol.)
862,300
Day's Range
3.68 - 3.89
52-Week Range
2.94 - 6.85
Dividend & Yield
N/A (N/A)
GALT Stock Predictions, Articles, and Galectin Therapeutic News
25 Biotechnology Stocks to Buy Now
25 Biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").
Hottest Manufacturing Stocks Now – ARRY CHMT SMMT SELB
The following stocks were moving the Manufacturing sector today.
Biggest Movers in Manufacturing Stocks Now – GALT CERC OVAS EBIO
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
13 Biotechnology Stocks to Sell Now
The ratings of 13 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
29 Biotechnology Stocks to Sell Now
This week, the overall grades of 29 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
28 Biotechnology Stocks to Sell Now
This week, the overall grades of 28 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
27 Biotechnology Stocks to Sell Now
The ratings of 27 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Biotech Stocks With Upside Target Ebola, Liver Disease
Developing successful Ebola and liver disease treatments is an incredibly risky opportunity for biotech stocks to create value.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
C
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
